Piotr Pobrotyn

Prof. Piotr Pobrotyn


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2025 in Cancers
Verified
Journal Article
Open access
PDF file
MPMonika Pajewska
Monika Pajewska
OPOlga Partyka
Olga Partyka
ACAleksandra Czerw
Aleksandra Czerw
ADAndrzej Deptała
Andrzej Deptała
KSKatarzyna Sygit
Katarzyna Sygit
Remigiusz KozlowskiRemigiusz Kozlowski
Remigiusz Kozlowski
Globally, breast cancer is both the most common cancer and the most common cause of death related to cancer among women. It is estimated that over 2 million women were diagnosed with breast cancer in 2022 worldwide, while almost 400,000 were diagnosed in the EU. Breast cancer has different histopathological subtypes that require different therapeutic approaches. Triple-negative breast cancer (TNBC) is a type that is considered more aggressive; it occurs in about 10 to 20% of all breast cancer cases. Approximately 40% of women initially diagnosed with TNBC will develop metastases. The objective of this study is to present current clinical trials focused on new treatment of advanced and metastatic TNBC. The study was conducted by searching the clinicaltrials.gov database. Due to the scope of this paper, primary endpoints in the included studies were objective response rate, treatment-emergent adverse events or serious adverse events, progression-free survival, and probability of pathologic complete response. Some of the selected studies were phase I or II RCTs; therefore, we should carefully examine their future results and implications for clinical guidelines.

24 August 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
PPPiotr Pobrotyn
Piotr Pobrotyn
APAleksandra Helena Pasieczna
Aleksandra Helena Pasieczna
DDDorota Diakowska
Dorota Diakowska
BUBartosz Uchmanowicz
Bartosz Uchmanowicz
GMGrzegorz Mazur
Grzegorz Mazur
AKAleksandra Kołtuniuk
Aleksandra Kołtuniuk
Frailty syndrome (FS) often coexists with many diseases of the elderly, including arterial hypertension, and may affect the disease course and adherence to therapeutic recommendations. This study aimed to evaluate the relationship between frailty and adherence to therapeutic recommendations in elderly hypertensive patients. The study included 259 patients hospitalized between January 2019 and November 2020 due to exacerbation of hypertension symptoms. Medical records were used to obtain basic sociodemographic and clinical data. The study was based on the Tilburg Frailty Indicator (TFI) and the Hill–Bone Scale (HBCS). The obtained data were analyzed within a cross-sectional design. The mean frailty score indicated by the TFI questionnaire was 7.09 ± 3.73. The most prominent FS component was associated with the physical domain (4.24 ± 2.54). The mean overall adherence measured with the HBCS was 20.51 ± 3.72. The linear regression model testing the Hill–Bone “reduced sodium intake” score against the TFI domains showed no relationships between the variables. Another regression model for the Hill–Bone “appointment-keeping” subscale indicated significant predictors for physical and social TFI domains (p = 0.002 and p < 0.0001, respectively). For the Hill–Bone “taking antihypertensive drugs” variable, the regression model found significant relationships with all TFI domains: physical (p < 0.0001), psychological (p = 0.003) and social (p < 0.0001). Our study suggests that frailty in patients with arterial hypertension can negatively impact their adherence to therapeutic recommendations.

15 September 2025 in Cancers
Verified
Journal Article
Open access
PDF file
IGIzabela Gąska
Izabela Gąska
ACAleksandra Czerw
Aleksandra Czerw
MPMonika Pajewska
Monika Pajewska
OPOlga Partyka
Olga Partyka
ADAndrzej Deptała
Andrzej Deptała
Remigiusz KozlowskiRemigiusz Kozlowski
Remigiusz Kozlowski
Breast cancer is the most common malignant cancer among women, following lung cancer in the general population

12 August 2024 in Healthcare
Verified
Journal Article
Open access
PDF file
OPOlga Partyka
Olga Partyka
MPMonika Pajewska
Monika Pajewska
ACAleksandra Czerw
Aleksandra Czerw
KSKatarzyna Sygit
Katarzyna Sygit
Oleh LyubinetsOleh Lyubinets
Oleh Lyubinets
Remigiusz KozlowskiRemigiusz Kozlowski
Remigiusz Kozlowski
In 2020 it is estimated that 281 million people were international migrants. Migrants constitute a potentially vulnerable population in terms of facing discrimination, poor living and housing conditions, and insufficient access to healthcare services. Due to the armed conflict in Ukraine in 2022, almost 10 million people crossed the Polish border within a year of the outbreak of the conflict. The objective of this paper is to present the use of primary healthcare services by people migrating from Ukraine to Poland and identify the barriers in access to healthcare by this group of persons. This study used a qualitative research technique in the form of an expert interview using individual in-depth interviews (IDI). The study group consisted of professionally active primary healthcare providers (doctors, nurses, and facility managers) in Poland. Research was carried out in the areas regarding the availability of healthcare, the potential threats and challenges, and possible system solutions. The results showed that the most common cause for doctor’s appointments among migrants are respiratory infections, including COVID-19. Many cases were related to back pain, mainly resulting from the physical work of the patients. Additionally, some barriers to access and the provision of healthcare services for patients from Ukraine were identified. The majority (75%) of respondents indicated language as a significant barrier when providing services. Based on the study results, we recommend creating a dedicated website and telephone hotline for this group of persons as well as the use of traditional media to distribute information about access to healthcare services. It is also essential to focus on assistance for older people, since they may experience more difficulties with language and navigating the healthcare system.

23 June 2024 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
JDJarosław Drobnik
Jarosław Drobnik
PPPiotr Pobrotyn
Piotr Pobrotyn
MBMária Belovičová
Mária Belovičová
KMKatarzyna Madziarska
Katarzyna Madziarska
Malgorzata TrochaMalgorzata Trocha
Malgorzata Trocha
MBMateusz Baran
Mateusz Baran
Background: In the last two decades, a significant increase in the number of Clostridioides difficile infection (CDI) cases has been observed. It is understandable to attempt to determine the factors that can predict the severity of the course of the infection and identify patients at risk of death. This study aimed to analyze the factors affecting the incidence and mortality of CDI in inpatient treatment at the University Clinical Hospital in Wrocław in 2016–2018. Methods: Statistical analysis of data obtained from patients’ medical records was performed. Only patients with symptoms of infection and infection confirmed by laboratory tests were enrolled in the study. When analyzing the number of deaths, only adult patients who died in hospital wards were included. The quantitative data including laboratory tests, used antibiotics and Nutritional Risk Screening (NRS) were assessed. Also, the qualitative data such as sex, year of hospitalization, occurrence of diarrhoea on admission to the hospital, presence of additional diseases, as wee ad the use of antibacterial drugs or proton pump blockers and ranitidine during hospitalization were analyzed. Results: A total of 319 adult CDI patients (178 women and 141 men) were enrolled of which 80 people died (50 women and 30 men). The mean age of the patients was 72.08 ± 16.74 years. Over the entire period studied, the morbidity was 174 cases per 100,000 hospitalizations while mortality was 25.08%. The group of deceased patients was characterized by: older age (by 9.24 years), longer duration of hospitalization (by 10 days), reduced albumin levels (Rho = -0.235, p < 0.001), higher urea levels, use of more antibiotics, higher risk of malnutrition in NRS (Rho = 0.219, p < 0.001), higher incidence of sepsis, heart failure, stroke, hypothyroidism. Pneumonia was diagnosed twice as often. It was also shown that deceased patients were significantly more likely to take penicillin and fluoroquinolones. Conclusions: In this study, the morbidity was lower, but mortality was higher compared to similar hospitals in Poland. CDI patients were characterized by older age, multimorbidity, extended hospitalization, and the use of broad-spectrum antibiotics. Risk factors for death included advanced age, prolonged hospital stays, lower albumin, higher urea, malnutrition, and comorbidities like heart failure, stroke, pneumonia, sepsis, and hypothyroidism. Increased antibiotic use, particularly penicillin and fluoroquinolones, was associated with a higher mortality risk.

29 April 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ACAleksandra Czerw
Aleksandra Czerw
ADAndrzej Deptała
Andrzej Deptała
MGMariola Głowacka
Mariola Głowacka
OPOlga Partyka
Olga Partyka
MPMonika Pajewska
Monika Pajewska
Remigiusz KozlowskiRemigiusz Kozlowski
Remigiusz Kozlowski
Screening is widely considered one of the most effective methods for the early detection of prostate cancer. Early detection allows for prompt treatment, which increases the likelihood of a full recovery. This review sought to summarize studies on screening methods related to prostate cancer. It examined trends in screening practices and organized the findings into two main categories. The first category focused on strategies to boost screening participation, reach underserved populations, and improve public awareness of health issues. The second category concentrated on refining current diagnostic methods, developing new tests, and testing biomarkers. A significant portion of the research also explored diagnostic techniques aimed at enhancing patient comfort during exams without compromising clinical effectiveness.